156 related articles for article (PubMed ID: 26360775)
1. Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.
Rifatbegovic F; Abbasi MR; Taschner-Mandl S; Kauer M; Weinhäusel A; Handgretinger R; Ambros PF
PLoS One; 2015; 10(9):e0137995. PubMed ID: 26360775
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF
Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546
[TBL] [Abstract][Full Text] [Related]
3. Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.
Abbasi MR; Rifatbegovic F; Brunner C; Ladenstein R; Ambros IM; Ambros PF
Mol Oncol; 2015 Mar; 9(3):545-54. PubMed ID: 25467309
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.
Stigliani S; Scaruffi P; Lagazio C; Persico L; Carlini B; Varesio L; Morandi F; Morini M; Gigliotti AR; Esposito MR; Viscardi E; Cecinati V; Conte M; Corrias MV
Oncotarget; 2015 May; 6(15):13295-308. PubMed ID: 25980492
[TBL] [Abstract][Full Text] [Related]
6. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
[TBL] [Abstract][Full Text] [Related]
7. Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers.
Merugu S; Chen L; Gavens E; Gabra H; Brougham M; Makin G; Ng A; Murphy D; Gabriel AS; Robinson ML; Wright JH; Burchill SA; Humphreys A; Bown N; Jamieson D; Tweddle DA
Clin Cancer Res; 2020 Jan; 26(1):122-134. PubMed ID: 31767563
[TBL] [Abstract][Full Text] [Related]
8. Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
Watson MA; Ylagan LR; Trinkaus KM; Gillanders WE; Naughton MJ; Weilbaecher KN; Fleming TP; Aft RL
Clin Cancer Res; 2007 Sep; 13(17):5001-9. PubMed ID: 17785550
[TBL] [Abstract][Full Text] [Related]
9. Differential RNA Expression Between Metastatic and Primary Neuroblastoma Cells.
Lee WG; Asuelime GE; Asuelime-Smith MBT; Chen SY; Kim ES
J Surg Res; 2024 Jun; 298():240-250. PubMed ID: 38631173
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
11. Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse.
Loh AHP; Angelina C; Wong MK; Tan SH; Sukhatme SA; Yeo T; Lim SB; Lee YT; Soh SY; Leung W; Chang KTE; Chua YW; Alkaff SMF; Lim TKH; Lim CT; Chen ZX
Front Oncol; 2022; 12():939460. PubMed ID: 36176417
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.
Morandi F; Scaruffi P; Gallo F; Stigliani S; Moretti S; Bonassi S; Gambini C; Mazzocco K; Fardin P; Haupt R; Arcamone G; ; Pistoia V; Tonini GP; Corrias MV
PLoS One; 2012; 7(1):e29922. PubMed ID: 22253825
[TBL] [Abstract][Full Text] [Related]
13. Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
Abbasi MR; Rifatbegovic F; Brunner C; Mann G; Ziegler A; Pötschger U; Crazzolara R; Ussowicz M; Benesch M; Ebetsberger-Dachs G; Chan GCF; Jones N; Ladenstein R; Ambros IM; Ambros PF
Clin Cancer Res; 2017 Aug; 23(15):4224-4232. PubMed ID: 28228384
[No Abstract] [Full Text] [Related]
14. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell.
Hansford LM; McKee AE; Zhang L; George RE; Gerstle JT; Thorner PS; Smith KM; Look AT; Yeger H; Miller FD; Irwin MS; Thiele CJ; Kaplan DR
Cancer Res; 2007 Dec; 67(23):11234-43. PubMed ID: 18056449
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells in the bone marrow - chances and consequences of microscopical detection methods.
Ambros PF; Mehes G; Ambros IM; Ladenstein R
Cancer Lett; 2003 Jul; 197(1-2):29-34. PubMed ID: 12880956
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression].
Druĭ AE; Shorikov EV; Tsaur GA; Popov AM; Tuponogov SN; Savel'ëv LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2014; 60(2):57-62. PubMed ID: 24919263
[TBL] [Abstract][Full Text] [Related]
17. A NOTCH3 transcriptional module induces cell motility in neuroblastoma.
van Nes J; Chan A; van Groningen T; van Sluis P; Koster J; Versteeg R
Clin Cancer Res; 2013 Jul; 19(13):3485-94. PubMed ID: 23649002
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.
Grau E; Martinez F; Orellana C; Canete A; Yañez Y; Oltra S; Noguera R; Hernandez M; Bermúdez JD; Castel V
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1415-21. PubMed ID: 20140741
[TBL] [Abstract][Full Text] [Related]
19. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
Träger C; Vernby A; Kullman A; Ora I; Kogner P; Kågedal B
Int J Cancer; 2008 Dec; 123(12):2849-55. PubMed ID: 18814238
[TBL] [Abstract][Full Text] [Related]
20. In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies.
Faulkner LB; Garaventa A; Paoli A; Tintori V; Tamburini A; Lacitignola L; Veltroni M; Lo Piccolo MS; Viscardi E; Milanaccio C; Tondo A; Spinelli S; Bernini G; De Bernardi B
J Clin Oncol; 2000 Nov; 18(22):3829-36. PubMed ID: 11078496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
